Category: Latest News

  • Woodside Energy Tops Revenue Estimates as Sangomar Field Boosts Output

    Woodside Energy Tops Revenue Estimates as Sangomar Field Boosts Output

    Woodside Energy Group Ltd (NYSE:WDS) posted stronger-than-expected second-quarter revenue of $3.27 billion on Wednesday, surpassing analyst projections of $3.16 billion. The beat was fueled by continued success at its Sangomar development and solid operational performance across its asset base. Shares rose 0.67% in premarket trading following the earnings report. The Australian energy producer delivered quarterly…

  • TE Connectivity Shares Tick Higher After Record Q3 Sales and Margins Beat Expectations

    TE Connectivity Shares Tick Higher After Record Q3 Sales and Margins Beat Expectations

    TE Connectivity Ltd. (NYSE:TEL) delivered better-than-expected third-quarter results on Wednesday, buoyed by outstanding performance in its Industrial segment and record-setting operational metrics. Following the announcement, shares edged up 0.99% in premarket trading. The industrial technology firm reported adjusted earnings per share of $2.27, topping Wall Street’s estimate of $2.08. Revenue climbed to a record $4.5…

  • Thermo Fisher Rises as Q2 Earnings and Revenue Beat Wall Street Forecasts

    Thermo Fisher Rises as Q2 Earnings and Revenue Beat Wall Street Forecasts

    Thermo Fisher Scientific Inc. (NYSE:TMO) reported better-than-expected financial results for the second quarter, with both profit and revenue surpassing analysts’ estimates. The scientific instruments and healthcare giant posted adjusted earnings per share of $5.36, exceeding the consensus forecast of $5.23. Revenue came in at $10.85 billion, marking a 3% increase year-over-year and outpacing the expected…

  • Travel + Leisure Q2 EPS Misses Expectations Despite Revenue Growth

    Travel + Leisure Q2 EPS Misses Expectations Despite Revenue Growth

    Travel + Leisure Co. (NYSE:TNL) fell just short of Wall Street’s earnings projections for the second quarter, even as the company reported better-than-expected revenue and continued momentum in its core vacation ownership division. The travel services provider posted adjusted earnings per share of $1.65, a cent below analysts’ forecast of $1.66. Revenue, however, reached $1.02…

  • Amazon Reportedly Shuttering Shanghai AI Lab Amid Heightened U.S.-China Strains

    Amazon Reportedly Shuttering Shanghai AI Lab Amid Heightened U.S.-China Strains

    Amazon (NASDAQ:AMZN) is reportedly shutting down its artificial intelligence research lab in Shanghai, a move that highlights the growing challenges American tech companies face in China, according to a Financial Times report released Wednesday. The closure comes as diplomatic and regulatory tensions escalate between the United States and China, with U.S. authorities increasingly tightening oversight…

  • Capital One Beats Q2 Expectations Despite Discover-Related Hit; Shares Climb

    Capital One Beats Q2 Expectations Despite Discover-Related Hit; Shares Climb

    Capital One Financial (NYSE:COF) delivered stronger-than-expected adjusted earnings for the second quarter, despite reporting a steep net loss tied to its recent acquisition of Discover Financial Services. The company’s $35.3 billion all-stock acquisition, finalized in May, made it the largest credit card issuer in the U.S. by outstanding balances. Earnings Overview The firm posted adjusted…

  • Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery

    Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery

    Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical firm pioneering therapies delivered through the suprachoroidal space (SCS®), announced today that Health Canada has officially approved XIPERE® (triamcinolone acetonide injectable suspension) for suprachoroidal administration in patients with uveitic macular edema (UME). This regulatory milestone makes Canada the latest country to authorize XIPERE, which is now approved in the…

  • Dow Jones, S&P, Nasdaq, Markets rise on U.S.-Japan trade deal; eyes on Alphabet and Tesla earnings

    Dow Jones, S&P, Nasdaq, Markets rise on U.S.-Japan trade deal; eyes on Alphabet and Tesla earnings

    U.S. stock futures climbed Wednesday amid optimism following a new trade agreement between the United States and Japan. The White House described the pact, which imposes a lower tariff rate on Japanese imports than originally announced by President Donald Trump, as “massive.” Attention now turns to a wave of corporate earnings, with tech giants Alphabet…

  • U.S. Dollar Stabilizes Near Two-Week Lows Ahead of Key Housing Report

    U.S. Dollar Stabilizes Near Two-Week Lows Ahead of Key Housing Report

    The U.S. dollar steadied on Wednesday following three days of declines but remains close to its lowest level in two weeks, buoyed by renewed investor confidence stemming from the recently announced U.S.-Japan trade agreement. At 04:10 ET (08:10 GMT), the Dollar Index, which tracks the greenback against a basket of six currencies, was steady around…

  • Oil Prices Gain on U.S.-Japan Trade Deal and Declining U.S. Crude Stocks

    Oil Prices Gain on U.S.-Japan Trade Deal and Declining U.S. Crude Stocks

    Oil prices edged higher in Asian trading on Wednesday, buoyed by optimism following a new trade agreement between the United States and Japan, along with data showing a drop in U.S. crude inventories. As of 22:07 ET (02:07 GMT), September Brent futures increased by 0.4% to $68.84 per barrel, while West Texas Intermediate (WTI) futures…